Robotic vs Open Pancreatoduodenectomy: BMJ | July 2026

Introduction:

Pancreatoduodenectomy remains one of the most complex abdominal operations. Robotic pancreatoduodenectomy (RPD) has been proposed to improve postoperative recovery, but robust randomized evidence has been limited. The PORTAL trial compared robotic and open pancreatoduodenectomy in high-volume expert centers.

Why was this study needed?

• High-quality randomized evidence comparing robotic and open pancreatoduodenectomy has been limited.
• Previous minimally invasive studies raised concerns regarding safety and learning curves.
• Whether robotic surgery improves recovery without compromising oncological outcomes remained uncertain.
• The higher costs of robotic surgery require justification through meaningful clinical benefits.
• Evidence was needed to guide future surgical practice and recommendations.

Results:

• Robotic pancreatoduodenectomy significantly accelerated postoperative functional recovery, resulting in earlier discharge despite a longer operative time.
• Postoperative complications, 90-day mortality, and oncological outcomes were comparable between robotic and open surgery, confirming the safety of the robotic approach in experienced centers.
• Robotic surgery incurred higher hospital costs, highlighting the importance of careful patient selection, institutional expertise, and procedural volume.

Clinical Impact:

This landmark phase III randomized trial demonstrates that robotic pancreatoduodenectomy can safely enhance postoperative recovery when performed by experienced surgeons in high-volume centers. However, the increased financial cost means that widespread implementation should be guided by institutional expertise, case volume, and healthcare resource availability.

Bottom Line:

Robotic pancreatoduodenectomy offers faster recovery with similar safety and oncological outcomes compared with open surgery, but at a higher cost. In expert, high-volume centers, it represents an effective minimally invasive alternative, although broader adoption should remain selective and value-based.